Verona Pharma (VRP)

 

Latest News

Verona to issue shares

Verona Pharma has announced that it will issue 133,333 new ordinary shares following an exercise of share options by N+1...

Verona Pharma plc : Miscellaneous

Verona Pharma plc: Miscellaneous Issue of Shares September 19, 2017, London - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces that it will issue 133,333 new ordinary shares in the capital of the Comp...

Verona Pharma Announces Positive Top-Line Data from Phase 2a Clinical Trial in COPD with RPL554 Dosed in Addition to Tiotropium (Spiriva®)

Verona Pharma Announces Positive Top-Line Data from Phase 2a Clinical Trial in COPD with RPL554 Dosed in Addition to Tiotropium (Spiriva) Achieved significant and clinically meaningful additional improvement in peak lung function and faster onset-of-action when added to tiotropium Demonstrated statistical significance across all primary and secondary ef...

Verona Pharma Appoints Stifel as Nominated Adviser

Verona Pharma Appoints Stifel as Nominated Adviser LONDON,Sept. 01, 2017 (GLOBE NEWSWIRE) --Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, is pleased to announce the appointment of Stifel Nicolau...

All News

DateHeadlineSource
19-09-17Verona to issue sharesStockMarketWire
19-09-17Verona Pharma plc : MiscellaneousRNS
07-09-17Verona Pharma Announces Positive Top-Line Data from Phase 2a Clinical Trial in COPD with RPL554 Dosed in Addition to Tiotropium (Spiriva®)RNS
01-09-17Verona Pharma Appoints Stifel as Nominated AdviserRNS
21-08-17Director Deals - Verona Pharma PLC (VRP)StockMarketWire
21-08-17PDMR DealingRNS
08-08-17Verona Pharma losses widen as it starts clinical trialsStockMarketWire
08-08-17Verona Pharma plc Interim Results for the Six Months Ended June 30, 2017 and Clinical Development UpdateRNS
02-08-17Verona Pharma to Announce Interim Results for Six Months Ended June 30, 2017 and Provide Clinical Development UpdateRNS
01-08-17Verona to present at healthcare conferenceStockMarketWire
01-08-17Verona Pharma to Present at 2017 Wedbush PacGrow Healthcare ConferenceRNS
26-07-17Verona Pharma Doses First Patients in Phase 2b Clinical Trial of RPL554 for COPD Maintenance TreatmentRNS
27-06-17Verona nears Phase 2b clinical trial for RPL554StockMarketWire
27-06-17Verona Pharma Receives Regulatory Approval to Commence Phase 2b Clinical Trial of RPL554 for COPD Maintenance Treatment in Five Countries across EuropeRNS
22-06-17Verona Pharma Appoints Dr. Desiree Luthman as Vice President of Regulatory AffairsRNS
06-06-17Verona Pharma plc : Holding(s) in CompanyRNS
06-06-17Verona Pharma plc : Holding(s) in CompanyRNS
05-06-17Verona initiates US clinical pharmacokinetic study for RPL554StockMarketWire
05-06-17Verona Pharma Initiates U.S. Clinical Pharmacokinetic Study for RPL554 Following Acceptance of IND Application by FDARNS
30-05-17Holding(s) in CompanyRNS
30-05-17Holding(s) in CompanyRNS
25-05-17Holding(s) in CompanyRNS
25-05-17Verona Pharma Announces Further Exercise of Over-Allotment Option and Resulting Total Voting RightsRNS
23-05-17Verona CEO to present at Jefferies Healthcare ConferenceStockMarketWire
23-05-17Verona Pharma to Present at Jefferies 2017 Global Healthcare ConferenceRNS
23-05-17Holding(s) in CompanyRNS
22-05-17Broker Forecast - Jefferies International issues a broker note on Verona Pharma PLCStockMarketWire
16-05-17Partial Exercise of Over-Allotment OptionRNS
08-05-17Holding(s) in CompanyRNS
05-05-17Holding(s) in CompanyRNS
05-05-17Holding(s) in CompanyRNS
05-05-17Holding(s) in CompanyRNS
03-05-17Holding(s) in CompanyRNS
03-05-17Block Listing Application and ReviewRNS
03-05-17Grant of Options and RSUs and PDMR DealingsRNS
02-05-17Closing of Global Offering and Total Voting RightsRNS
02-05-17Director/PDMR ShareholdingRNS
28-04-17Director Deals - Verona Pharma PLC (VRP)StockMarketWire
28-04-17Director/PDMR ShareholdingRNS
27-04-17Pricing of Offering and Approval to List on NASDAQRNS

RSS feeds

  • Editorial news feed for LSE:VRP Editorial
  • Regulatory news feed for LSE:VRP Regulatory